APT Medical Inc
SSE:688617
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
231.673
439
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
APT Medical Inc
Total Liabilities
APT Medical Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
A
|
APT Medical Inc
SSE:688617
|
Total Liabilities
ÂĄ665.8m
|
CAGR 3-Years
73%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Liabilities
ÂĄ3.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
20%
|
CAGR 10-Years
24%
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Liabilities
ÂĄ21.8B
|
CAGR 3-Years
33%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
||
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Total Liabilities
ÂĄ2.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Total Liabilities
ÂĄ9.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
39%
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Liabilities
ÂĄ6.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
APT Medical Inc
Glance View
APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 1,511 full-time employees. The company went IPO on 2021-01-07. The firm's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The firm's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The firm is also engaged in related original equipment manufacturer (OEM) business. The firm distributes its products within domestic market and to overseas markets.
See Also
What is APT Medical Inc's Total Liabilities?
Total Liabilities
665.8m
CNY
Based on the financial report for Dec 31, 2023, APT Medical Inc's Total Liabilities amounts to 665.8m CNY.
What is APT Medical Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
64%
Over the last year, the Total Liabilities growth was 44%. The average annual Total Liabilities growth rates for APT Medical Inc have been 73% over the past three years , 64% over the past five years .